Evidence has emerged in the last two decades that at the molecular level most chronic
diseases, including cancer, are caused by a dysregulated inflammatory response. The …

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive
diseases associated with poor outcome. Studies that focus specifically on PTCL are …

Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms
with generally poor clinical outcome. Currently 50% of PTCL cases are not classifiable …

The molecular alterations underlying the pathogenesis of angioimmunoblastic T-cell
lymphoma (AITL) and peripheral T-cell lymphoma, unspecified (PTCL-u) are largely …

Peripheral T-cell lymphoma (PTCL) is often challenging to diagnose and classify. Gene
expression profiling was performed on 144 cases of PTCL and natural killer cell lymphoma …

Peripheral T cell lymphoma, unspecified (PTCL/U), the most common form of PTCL, displays
heterogeneous morphology and phenotype, poor response to treatment, and poor …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial
origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs) …

Angioimmunoblastic lymphoma (AILT) is the second most common subtype of peripheral T-
cell lymphoma (PTCL) and is characterized by dismal prognosis. Thus far, only a few studies …

With the use of microarray gene-expression profiling, we analyzed a homogeneous series of
32 patients with systemic anaplastic large-cell lymphoma (ALCL) and 5 ALCL cell lines …

Objective: Retrospective data shows that peripheral T‐cell lymphoma (PTCL) patients
sensitive to conventional chemotherapy for aggressive lymphomas may respond better if this …